Degenerative cervical myelopathy (DCM) results from compression of the spinal cord and represents the predominant cause of cervical spinal cord dysfunction amongst adults in developed countries.  After initial presentation with neurological symptoms such as limb numbness, weakness, dexterity impairment and gait disturbance, patients invariably undergo progressive neurological decline.  Untreated, patients may be rendered chairbound, incontinent, and require significant assistance with daily living.  The burden of DCM is expected to increase globally with the aging population.  Whilst surgical decompression is effective in attenuating as well as partially reversing neurological decline, gaps to management remain in there being a substantial delay in diagnosis, lack of prognosticative tools, and an absence of effective non-surgical treatment options.